Prof. Dr. Heike Wachenhausen is the founding Partner of the Lübeck-based law firm Wachenhausen Rechtsanwälte, which was established in 2013. She focuses her practice on regulatory matters related to the development, manufacture, transport and distribution of medicinal products and medical devices.
Prof. Dr. Wachenhausen started her own practice in Lübeck in 2011. Prior to that, she worked as Head Legal in the Legal Department of Novartis Pharma AG in Basel, where she was responsible for the division Regulatory & Development. Prior to her in-house experience, she worked as a lawyer at Sträter Rechtsanwälte in Bonn (2003 to 2009) and Clifford Chance in Düsseldorf (2000 to 2003). In both law firms, she advised pharmaceutical and medical devices companies as well as medical institutions and doctors.
Since December 2017 she holds a honorary professorship at the University of Applied Sciences Lübeck.
She has also been the author of a number of relevant publications and is an experienced speaker at professional events and in-house trainings. Among other things, she annotates Sections 40 et seqq. of the German Medicinal Products Act concerning clinical trials of medicinal products involving human subjects in the legal commentary Arzneimittelgesetz by Kügel / Müller / Hofmann. In addition, she is an editor of the legal commentary WiKo – Medizinprodukterecht by Hill / Schmitt and the co-publisher of the Medizinproduktejournal (MPJ).
Languages: German, English